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stroke treatment process was carried out in 2013. We evaluated time delay, symptomatic intracerebral hemorrhage, and clinical
recovery of patients before and after the reorganization. We used multivariable linear regression to estimate the change in
door-to-needle time before and after the reorganization.
Results: A total of 107 patients with comparable data were treated with tissue plasminogen activator in 2009 to 2012 (group 1) and
46 patients were treated during 12 months in 2013 to 2014 (group 2). Median door-to-needle time was 54 minutes before the
reorganization and 20 minutes after it (statistical estimate of difference 32 minutes; 95% conﬁdence interval 26 to 38 minutes).
After adjusting for several potential cofounders inmultivariable regression analysis, the only factor contributing to a signiﬁcant reduction
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INTRODUCTION
Background
Thrombolysis with tissue plasminogen activator (tPA)
is a cornerstone in treating a patient with acute ischemic
stroke.1,2 This treatment should be given as soon as
possible, preferably within 4.5 hours after symptom onset
and within 60 minutes after patient arrival at the hospital.1
Previous studies have shown that a median door-to-needle
(DNT) time of 20 minutes is achievable.3 Each minute
saved from the time to treatment can produce signiﬁcant
improvement in a patient’s poststroke life.4
Various strategies for improving door-to-needle time
have been presented previously.5 After having begun2 : February 2019postgraduate training in the nationally new specialty of
emergency medicine in our hospital,6 we changed
the treatment of acute ischemic stroke from the use
of telestroke to a model based on a strong contribution
of emergency physicians. We recently reported the
basic principles and preliminary results of this new model.7
The primary aim of this study was to analyze median
door-to-needle time together with safety data of tPA-
treated acute ischemic stroke patients during the ﬁrst 12
months of the emergency physician–based protocol. These
results are compared with those in 2009 to 2012, preceding
reorganization of the acute ischemic stroke protocol.
Secondarily, we aimed to reveal whether onset-to-treatment
(OTT) time was affected after the reorganization. Safety
data are compared with international data as well.Annals of Emergency Medicine 105
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What is already known on this topic
Most stroke teams are led by neurologists, whereas
emergency physicians typically are the ﬁrst to evaluate
and treat patients with acute neurologic deﬁcits.
What question this study addressed
What was the effect of a reorganization of the acute
stroke process to focus on emergency physicians
guiding acute stroke care?
What this study adds to our knowledge
Stroke patients were treated faster after the
reorganization. Although complications were similar
before and after the change, the study was not
powered to conﬁrm their equivalency.
How this is relevant to clinical practice
With training and a well-deﬁned protocol, emergency
physicians quickly treated patients with acute stroke.MATERIALS AND METHODS
This was a before-after intervention analysis, and its
design was approved by the local ethics committee. The
study included all patients with acute ischemic stroke who
were treated with tPA in our emergency department (ED)
in 2009 to 2012 (group 1, ie, “before”) and from October
1, 2013, to September 30, 2014 (group 2, ie, “after”). In
2009 to 2012, before the implementation of the emergency
medicine specialty, the treatment protocol of patients with
acute ischemic stroke varied slightly, as described in one of
our earlier studies.7 Thereafter, stroke education for
emergency physician trainees took place during the 9-
month reorganization period preceding October 1, 2013.7
It consisted of training in the stroke unit at the neurology
ward, theoretical teaching and practical training in
diagnosing and treating patients with acute ischemic stroke
(eg, diagnosis and differential diagnosis of acute ischemic
stroke, National Institutes of Health Stroke Scale [NIHSS]
scoring with indications and contraindications of tPA
administration), preparation with the electronic patient
record after the prenotiﬁcation given by emergency medical
services (EMS), shadowing of an experienced neurologist in
acute neurologic emergencies, and ﬁnally with the diagnosis
and treatment of their own patients with clinical acute
ischemic stroke, under the supervision of the specialist in
the ED. Radiologists taught emergency physicians the
evaluation of head computed tomography (CT) of patients
with acute ischemic stroke. After training, radiologistsAnnals of Emergency Medicineremained on call and available continuously to evaluate
head CT images. Finally, we emphasized the importance of
the acute ischemic stroke process without extra delays in
our ED.7
Depending on the day of the week or the time of day,
the physician on call taking care of patients with acute
ischemic stroke was either a neurologist (or resident) or
internist resident working with the aid of telestroke
before the reorganization. Since October 1, 2013, the
responsible physician in the ED has been a stroke-educated
emergency physician in 97.5% of all out-of-hour shifts
during the ﬁrst year after the reorganization.7 The
neurologist on call was always reachable by telephone if
needed. Every emergency physician trainee in our ED
became stroke educated during the 9-month reorganization
period before October 1, 2013 (ie, the ofﬁcial start of our
program). However, because of the relatively small number
(n¼9) of our trainees, on a few occasions we had to rely on
experienced physicians who were not speciﬁcally stroke
educated. In these situations, the role of the senior
neurologist on call was emphasized.
The data were collected from patient ﬁles retrospectively
by using the relevant primary source data. The written
patient records consisted of 3 sources: the report from
EMS by paramedics; a paper form ﬁlled out in the ED by
nurses, which contained information from the clinical care
delivered and described during the stroke activation (time
of arrival and time of initiation of tPA); and the electronic
patient record generated by the responsible physician.
The paper form was considered a primary source if there
were any conﬂicts concerning the data that occurred after
patient arrival. For example, the time of patient entrance
and that of tPA bolus are primarily recorded on this paper.
Physicians usually later dictate the same information into
the electronic record. On the other hand, the onset of
symptoms is usually conﬁrmed by a physician and stored in
the electronic patient record. If there was any discrepancy
in the time of onset between data sources, the notation of
the attending physician in the ED was considered the true
value. The data were abstracted by the ﬁrst author (I.H.).
He read all patient records of tPA-treated patients and
collected the numeric information into the electronic
abstraction form. These data included precisely deﬁned
variables such as sex, age, NIHSS score, intervals (door-to-
needle and onset-to-treatment time), and presence of
intracerebral hemorrhages in both groups (intracerebral
hemorrhage at this point: yes or no). Missing data were
coded as such. Conﬂicting or ambiguous chart elements
had to be discussed with the senior researcher. However, in
our setting such data did not exist. This investigator was
not blinded to the period (pre- versus postintervention).Volume 73, no. 2 : February 2019
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treated with thrombolysis. Then, the numbers of adverse
hospital outcomes (inhospital mortality or impaired
recovery leading the patient to become permanently
bedridden) were abstracted from the electronic Efﬁca
patient database (version 1.5; Tieto Oy, Helsinki, Finland)
and other hospital sources by using the Web-based database
program Exreport (version 2.0; Neotide Oy, Vaasa,
Finland). The crucial data of each hospital stay are
nationally coded uniformly and can be accessed without
entering conﬁdential individual patient records.
Furthermore, the calculation of the 30-day mortality of all
patients with acute ischemic stroke was based on data
obtained from the Statistical Ofﬁce of Finland. The annual
results before the reorganization (ie, 2009 to 2012) are
presented as such, and the average mortality of these 4 years
is compared with that of 12 months after the reorganization.
For patients who received tPA treatment, we collected
individual data, including sex, age, NIHSS score, intervals
(door-to-needle and onset-to-treatment time), and presence
of intracerebral hemorrhages in both groups.
The modiﬁed Rankin Scale is commonly used to
measure disability in tPA-treated patients.8 It is a 7-level,
ordinal, noninterval scale in which 0 corresponds to no
symptoms; 5, to severe disability; and 6, to death.
Evaluation of clinical recovery by using the modiﬁed
Rankin Scale was not routine practice in our hospital until
2013. Since then, it has been used in all cases 3 months
after acute ischemic stroke9 by way of the modiﬁed Rankin
Scale–9Q questionnaire.10 So in this study, the modiﬁed
Rankin Scale score was recorded clinically in patient ﬁles
(only after reorganization) at 3 months after the tPA
treatment and collected from the patient ﬁles
retrospectively with the other data by investigators.
All tPA-treated patients were included in the analysis.
Exclusion criteria were as follows: symptomatic stroke in an
inhospital patient, symptom ﬂuctuation (ie, no evident
time for the start of index stroke symptoms), basilar artery
occlusion, discontinuation of tPA infusion before a full
dose (for example, because of low hemoglobin level), and
missing data on crucial times.
The safety of the new protocol was assessed by using the
European Cooperative Acute Stroke Study (ECASS II)
criteria.11 During the study periods, routine reimaging of
the brain by way of CT was carried out approximately 24
hours after tPA treatment if there were no patient-related
reasons for reimaging before that. Brain hemorrhages were
classiﬁed by using slightly modiﬁed ECASS II criteria:
intracerebral hemorrhage was deﬁned as symptomatic if
there was blood at any site in the brain on the CT scan
according to the radiologist and signiﬁcant clinicalVolume 73, no. 2 : February 2019worsening of the situation occurred; for example,
drowsiness and deepening of hemiparesis or an increase in
NIHSS score by 4 or more points. Other ﬁndings
concerning blood at any site of the brain but without
clinical effect were classiﬁed as asymptomatic. This
practical slight modiﬁcation was carried out because of the
retrospective setting: radiologists’ reports presented CT
reading panels and patient record notes indicated
“documentation by the investigator.”11 The interrater
reliability assessment was used when the intracerebral
hemorrhages were classiﬁed as asymptomatic and
symptomatic hemorrhages. This was accomplished in 2
phases. First, I.H. classiﬁed the patients without blinding
according to the information that was available from the
patient records (eg, the radiologist report of the head CT,
the clinical situation in the ED or in the stroke unit).
ECASS II criteria were used as described. Thereafter, before
further evaluation, each patient ﬁle was blinded so that the
group, date, and name of the patient or physician could not
be identiﬁed. Finally, an experienced neurologist (H.K.)
conducted the classiﬁcation for the same patients, using the
identical but blinded information.Methods of Measurement
Statistical analyses were performed by using IBM SPSS
Statistics (version 22; IBM, Chicago, IL). Differences of
dichotomous variables with 95% conﬁdence intervals (CIs)
with a correction for continuity were analyzed by using
public statistical software (http://vassarstats.net/prop2_ind.
html) according to a method described by Newcombe12
and derived from the procedure outlined by Wilson.13
Data are presented as median (minimum–maximum) if not
mentioned otherwise. We made a priori a sample size
calculation for the door-to-needle time (SD 40%), with the
presumed sampling ratio of 4:1. For the effect of 30%
(a¼.05, 2 tailed), we would have needed approximately 20
patients in group 2 to yield power of 80%.
Before we compared results before and after the
reorganization, we tested the homogeneity of the results
during 2009 to 2012. Dichotomous variables such as
proportions of stroke patients treated with tPA and the 30-
day mortality of all patients with acute ischemic stroke
before and after the reorganization were compared by c2
test. Because of small numbers, comparisons of adverse
hospital outcome of all ischemic stroke patients, all
intracerebral hemorrhages, and symptomatic versus
asymptomatic intracerebral hemorrhages were conducted
with Fisher’s exact test. The estimated differences of door-
to-needle time and onset-to-treatment time before and after
reorganization, with 95% CIs, were calculated by using theAnnals of Emergency Medicine 107
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test. Differences in continuous variables were assessed by
using the Mann-Whitney U test.
To analyze whether the reorganization as such had an
effect on door-to-needle time, our preplanned analysis was
to perform multivariable regression analysis including
collinearity statistics with the group and 9 well-known
biologically relevant variables possibly affecting door-to-
needle time. Factors used in the analysis were entered as
predictors as follows: age in years, sex (male or female),
year (from 2009 to 2014), home municipality (3 groups
based on the distance to the hospital), prenotiﬁcation
(from the EMS before patient arrival: yes or no), use of
telestroke consultation (yes or no), day of the week
(Saturday/Sunday versus other, ie, weekend [yes or no]),
hour of the day (ofﬁce hours versus out-of-ofﬁce hours),
NIHSS score at patient arrival to the ED, and the group (1
versus 2). Here, we were interested in the comparative
effects of these factors on door-to-needle time instead of
conducting any estimation or general modeling based on
our results.
In statistical analyses, P<.05 was considered signiﬁcant.RESULTS
Before the reorganization, 1,581 patients with acute
ischemic stroke were treated in our ED in 2009 to 2012.
Furthermore, 355 patients were treated during the 12
months after the reorganization. The proportions of
patients treated yearly with tPA were 7.9% (n¼29), 7.9%
(n¼33), 8.1% (n¼27), and 7.6% (n¼35) in 2009 to
2012, respectively. Taken together, the proportions of
tPA-treated patients with acute ischemic stroke before and
after the reorganization were 7.8% (n¼124) and 14.4%
(n¼51), respectively (difference 6.5%; 95% CI 2.8% to
10.9%). Of the 124 of patients in group 1, 17 wereFigure 1. The trial proﬁle was a before-after intervention analysis. G
year (from October 1, 2013, until September 30, 2014).
108 Annals of Emergency Medicineexcluded, 8 because of basilar artery occlusion or because of
an inhospital stroke and 9 because of insufﬁcient time data.
In group 2, the total number of patients was 51. Five of
them were excluded, 1 because of missing data, 1 because
tPA was started after symptom ﬂuctuation, 1 because the
tPA infusion was discontinued because of low hemoglobin
level, and 2 because of basilar artery occlusion.
When only tPA-treated patients without exclusion
criteria were counted, the yearly numbers were 25, 30, 21,
and 31 in 2009 to 2012, respectively. During these 4 years,
the percentage of tPA treatment varied from 6.3% to 7.2%,
without any temporal trend. Hence, the mean proportion
of this period could be compared with that of the 12-
month period after the reorganization. As a result, the total
numbers of patients included in further analyses were 107
in group 1 (2009 to 2012) and 46 in group 2 (2013 to
2014) (Figure 1). Proportions of tPA-treated patients with
acute ischemic stroke and without exclusion criteria before
(group 1) and after (group 2) the reorganization were 6.8%
and 13.0%, respectively (difference 6.2%; 95% CI 2.7% to
10.4%). The characteristics of the groups are presented in
the Table.
The median door-to-needle time was 54 minutes in
group 1 and 20 minutes in group 2 (statistical estimate of
difference 32 minutes; 95% CI 26 to 38 minutes)
(Figure 2A and B). According to multivariable regression
analysis, the only factor explaining door-to-needle time was
group. All assessed variance inﬂation factors were less than
10, so we did not ﬁnd evidence of multicollinearity. Results
of the model with all 10 of the potentially biologically
relevant predictors are given in Table E1, available online at
http://www.annemergmed.com.
The median onset-to-treatment time in group 1 was 135
minutes, whereas it was 119 minutes in group 2 (statistical
estimate of difference 23 minutes; 95% CI 6 to 39
minutes) (Figure 3).roup 1 (ie, “before”) represents 2009 to 2012; and group 2, 1
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Table. Study population and the main ﬁndings.
Study Population and Main Findings Group 1 Group 2
Patients included 107 46
Men (%) 50 (47) 28 (61)
NIHSS score, median (IQR) 7 (4–12) 5 (4–9)
DNT median, min 54 20
OTT median, min 135 119
Hospital mortality, No. patients 4 0
Mortality at 3 mo, No. patients NA 1
mRS 3 mo, median (IQR) NA 1 (0–3)
sICH, No. patients (%) 5 (4.7) 1 (2.2)
IQR, Interquartile range; OTT, onset-to-treatment time; NA, not applicable before the
reorganization; mRS, modiﬁed Rankin Scale score; sICH, symptomatic intracerebral
hemorrhage.
Figure 3. Median OTT was 135 minutes before reorganization
(group 1). After implementation of the new stroke protocol, it
was 119 minutes (group 2). The difference (statistical estimate
23 minutes; 95% CI 6 to 39 minutes) was signiﬁcant (P¼.006).
Heikkilä et al Fast Protocol for Treating Acute Ischemic StrokeIn group 2, the median modiﬁed Rankin Scale score 3
months after treatment was 1.0 (mean 1.6; data available
from 44 patients). Thirty-two of the 46 patients were
functionally independent, with a modiﬁed Rankin Scale
score of 0 to 2. These data were not available for group 1
because our hospital did not have a standard practice to
systematically assess outcomes at 90 days before the
reorganization.
Six cases of symptomatic intracerebral hemorrhages after
tPA treatment were detected, 5 of 107 (4.7%) in group 1
and 1 of 46 (2.2%) in group 2 (difference 2.5%; 95% CI
–8.7% to 9.2%) (Table). For the assessment of classifying
the intracerebral hemorrhages as asymptomatic and
symptomatic, I.H. and H.K. obtained the same results so
that the agreement of the symptomatic intracerebral
hemorrhages in both groups was 100%.Figure 2. A, Before the reorganization (group 1, 2009 to 2012), i
increase (NS). B, In group 1 (ie, “before,” 2009 to 2012), median
(group 2 [ie, “after,” 12 months from October 1, 2013]). The differe
was signiﬁcant. DNT as in A. Also shown is a back-to-back histogra
interquartile range. Whiskers and outliers (open circles) represent
DNTs were 20 minutes and 2 hours, 11 minutes, respectively. In g
Volume 73, no. 2 : February 2019Of tPA-treated patients with acute ischemic stroke, 4
(3.7%) in group 1 died during the hospital stay, whereas
none did in group 2 (difference 3.7%; 95% CI –6.2% to
9.9%) (Table). After the hospital stay, 57.9% (62 of 107)
and 63.0% (29 of 46) of patients with acute ischemic
stroke and tPA treatment were discharged home in groups
1 and 2, respectively (difference 5.1%; 95% CI –13.0% to
21.8%). The 30-day mortality of all ischemic stroke
patients (both tPA treated and untreated) was 8.1% before
and 7.5% after the reorganization of the stroke protocol in
our ED (difference 0.6%; 95% CI –0.4% to 1.6%). In
tPA-treated patients with acute ischemic stroke, the 3-
month mortality rate in group 2 was 2.2% (ie, only 1
patient of 46 died after treatment) (Table). Because there
were no reliable data on 3-month modiﬁed Rankin Scalen median DNTs there were no trends either to decrease or
DNT was 54 minutes. After reorganization, it was 20 minutes
nce (statistical estimate 32 minutes; 95% CI 26 to 38 minutes)
m representing same results. Box plots represent medians and
the whole range of DNTs. In group 1, minimum and maximum
roup 2, they were 8 and 60 minutes, respectively.
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was unavailable.
The diagnosis at discharge from the stroke unit in the
neurology department was associated with acute ischemic
stroke in all of the cases in group 2.LIMITATIONS
A limitation of our study is that it was retrospective and
modiﬁed Rankin Scale score data on patients treated before
2013 were available only in a limited number of cases.
Therefore, we were able to compare our modiﬁed Rankin
Scale score data from group 2 only with international
ﬁndings.14 Since 2013, modiﬁed Rankin Scale score
evaluation using the modiﬁed Rankin Scale–9Q10 has been
routine practice. As is well known, the modiﬁed Rankin
Scale has its own limitations,15 but it is still probably the
most relevant scale.9
A further limitation of this study is that as a single-center
study carried out in a medium-sized hospital, the total
number of tPA-treated patients was relatively low.
However, the number of tPA-treated patients during the
12-month observation period was 51 (46 included in
the study) of 355 patients with acute ischemic stroke, so
the proportion of patients with thrombolysis (14.4; 13.0%)
was relatively good compared with results published
earlier.16 After the reorganization, not only did door-to-
needle time and onset-to-treatment time decrease but also
the number of stroke patients per year who were treated
with tPA increased compared with that in previous years.
Because the median NIHSS score of the patients decreased
(Table) and simultaneously no stroke mimics were treated,
our study implies that, overall, reorganization of the stroke
protocol improved the treatment of patients with acute
ischemic stroke.
An important methodological limitation is similar to that
of many other studies in the ﬁeld of emergency medicine.17
Retrospective studies are always challenging and susceptible
to biases. Especially the chart-reviewing process in this study
was not perfect because the data abstracting and chart
reviewing were conducted by the authors. However,
especially when evaluating symptomatic intracerebral
hemorrhages, we tried to avoid biases by using blinded
double-check after an open evaluation. There was no
discrepancy between the open and blinded evaluations in
regard to symptomatic or asymptomatic intracerebral
hemorrhages.We did not ﬁnd the retrospective nature of this
study a major problem because the most important data (for
example, time and mortality data) are numeric and thus not
sensitive to subjective biases. Still, we are well aware of the
possibility of failure to train and monitor data abstractors, as110 Annals of Emergency Medicinedescribed in a review article by Vassar and Holzmann
according the considerations of retrospective chart review.18DISCUSSION
On the basis of our results in this single-center study,
emergency physicians were able to treat acute ischemic
stroke with tPA rapidly, without increasing intracerebral
hemorrhage, with the aid of neurologists on call over the
telephone if needed. Shortening of median door-to-needle
time to 20 minutes and onset-to-treatment time to 119
minutes was statistically signiﬁcant, and there was no
increase in the rate of symptomatic intracerebral
hemorrhages. Because we did not evaluate the subintervals
of door-to-needle time, we are not able to exactly show
where time saving actually occurred. One of the key points
is that the treatment protocol is always the same, without
any variations, and that the patient is examined
immediately after entrance to the ED.
Patient selection was adequate because no stroke mimics
were treated with tPA in group 1 nor 2, although small
sample size limits the generalization of our results. More
important, there is no evidence that any patient with acute
ischemic stroke during the latter study period would have
been left without tPA when indicated: according to the
systematic quality assurance in the neurology department
(including the stroke unit), no patient was missed in the
latter period (group 2). The use of the telestroke was
interrupted on September 30, 2013, so that it was not
available in the latter period (group 2).
There are ways to improve capacity efﬁciency in EDs
through, for example, optimizing work spaces; education;
cooperation of staff between EMS, EDs, and neurology and
radiology departments; reorganizing processes; and
implementation of bedside diagnostics.19-22 Our acute
ischemic stroke process represents a combination of these
(Figure 4).7
There is marked regional variation in thrombolysis
treatment.23 Some potential external and internal barriers
to the emergency use of tPA for acute ischemic stroke has
been recognized, including, for example, environmental
factors and outcome expectancy.24 Scott et al16 reported
the ﬁndings of an important Increasing Stroke Treatment
through Interventional behavioral Change Tactics
(INSTINCT) trial, in which they made an intervention
designed to alter systems and behavior at an institutional
level and individual staff level. In that study, the use of tPA
remained below 3% after having increased in both groups,
and the intervention had no signiﬁcant effect on alteplase
use in patients with acute ischemic stroke. The original aim
of our new protocol was to decrease the delay of treatment.Volume 73, no. 2 : February 2019
Figure 4. Main prerequisites and elements of the intervention. Modiﬁed from our earlier publication.7 INR, International
normalized ratio.
Heikkilä et al Fast Protocol for Treating Acute Ischemic StrokeSimultaneously, we succeeded in signiﬁcantly increasing
the proportion of tPA-treated patients with acute ischemic
stroke.
Comparison of the intracerebral hemorrhage and
recovery data with the Safe Implementation of
Thrombolysis in Stroke-Monitoring Study (SITS-MOST)
shows that our protocol had comparable safety and efﬁcacy.
In our study, symptomatic intracerebral hemorrhage in
group 2 was found in only 2.2% of the whole population,
according to ECASS II,11 whereas the percentage varies
between 1.6% and 7.3% in SITS-MOST, depending on
the particular criteria.14 Again, 70% of our patients had
modiﬁed Rankin Scale scores of 0 to 2 after 3 months
compared with 54.8% to 56.0% in SITS-MOST.14
To our knowledge, this study is the ﬁrst in which the
role of emergency physicians as important executors of a
stroke protocol with a very short median door-to-needle
time has been conﬁrmed. Greenberg et al25 presented
results in which emergency physicians trained in
neuroscience could achieve better results than their
colleagues without such training, with door-to-needle times
of 35 and 83 minutes, respectively. We carried out a search
in PubMed (2007 to November 2016; search terms
“Emergency physician” [Title/Abstract] OR “Emergency
physicians” [Title/Abstract] AND “stroke” [Title/Abstract]
AND “thrombolysis” [Title/Abstract]) that revealed a total
of 19 publications, including an earlier study of ours.7 Of
these, 15 were based on clinical studies, but only 2 reported
door-to-needle or onset-to-treatment times.26,27
An article by Ferrari et al26 focused on Austrian stroke
protocols and inhospital delays. They found that door-to-
needle times ranged between 30 and 78 minutes in
Austrian stroke centers in April 2004 to November 2012.
The study did not include emergency physician–led
protocols because the specialty of emergency medicine does
not exist in the country. Another clinical study concernedVolume 73, no. 2 : February 2019thrombolysis for acute ischemic stroke in a district general
hospital in the United Kingdom with an emergency
physician–led stroke team.27 The main ﬁnding of this
study was that thrombolysis is both safe and possible in a
nonspecialist center led by emergency physicians compared
with SITS-MOST register data.28 This study involved not
door-to-needle times but onset-to-treatment times. Their
ﬁnding of an onset-to-treatment time of 142 minutes is in
line with our results in group 1 (ie, before the
reorganization). In a third study, onset-to-treatment time
was available in only 4 cases, and it was focused mainly on
CT angiography in basilar artery occlusion with intubated
patients.29 One educational study revealed that the
Canadian system provided detailed stroke protocol
education for trainees in emergency medicine.30
To conclude, we found that implementation of a stroke
protocol based on the central role of emergency physicians
decreased both door-to-needle time and onset-to-treatment
time. Emergency physicians are able to treat stroke patients
quickly and efﬁciently once the acute ischemic stroke
protocol has been created, with cooperation between
neurologists, radiologists, and emergency physicians.
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